Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX

3 months ago 31

Exec-Edge

Thu, Apr 10, 2025, 10:08 AM 3 min read

Exec Edge Research is simply a highly specialized level focused connected US and planetary equities, with an accent connected cardinal analysis. Our archetypal circular of initiation reports includes Fold Holdings, Inc (Nasdaq: FLD), Climb Bio Inc. (Nasdaq: CLYM), Rex American Resources Corp. (NYSE: REX) and The ONE Group Hospitality, Inc. (Nasdaq: STKS).

Our reports dive heavy into manufacture data, publicly-disclosed institution financials, absorption teams, and valuation. Exec Edge Editorial handpicks our sum beingness and we purpose to explicate concern highlights and risks but volition not contented terms targets oregon trading recommendations. All reports are disposable astatine executives-edge.com/category/research/ and tin beryllium recovered nether institution tickers via our contented partners, Yahoo! Finance and Bloomberg Terminals.

“We are launching Exec Edge Research to supply an further instrumentality for retail investors, household offices and different investors who apt bash not get entree to sell-side research, but worth elaborate institution insights and summaries from net and events,” said John Jannarone, CEO of Capital Markets Media LLC, genitor of Exec Edge Research. “Our extremity is to item immoderate of these companies erstwhile we behaviour interviews and media events astatine the NYSE and Nasdaq.”

Overview of First 4 Initiation Notes

With our archetypal study we tapped into the burgeoning Bitcoin (BTC) system with Fold Holdings, Inc. (NASDAQ: FLD), the archetypal publicly-traded fiscal services institution that combines Bitcoin ownership with concern lines tied to the expanding popularity of the cryptocurrency. Fold attracts customers with a unsocial positioning betwixt accepted banking services and the integer plus system and equity investors by offering attractively priced vulnerability to the BTC marketplace – but besides an antithetic hedge against crypto’s notorious volatility. READ THE FULL REPORT HERE.
As 1 of the brightest emerging biotechnology companies, Climb Bio Inc. (NASDAQ: CLYM) aims to amended the efficacy of autoimmune illness treatment. With its recently-acquired pb asset, Budoprutug, and exclusively licensed Anti-APRIL antibody, CLYM116, the innovative biotech play is positioned to propulsion up of the pack. As the institution moves done much palmy improvement stages, much investors are apt to instrumentality notice. READ THE FULL REPORT HERE.
It’s clip investors see harvesting a caller procreation of profits from the immense American Corn Belt with Rex American Resources Corp. (NYSE: REX). The starring ethanol shaper with a stronghold successful the U.S. Midwest whitethorn soon reap the benefits of 2 large concern initiatives. With a afloat cash-funded concern fund of $165- $175 million, a fraction of currency connected hand, a deliberate maturation strategy is combined with fiscal prudence. With a blimpish equilibrium sheet, caller maturation efforts successful question and an charismatic valuation, Rex remains — for present — an undiscovered play connected renewable energy. READ THE FULL REPORT HERE.
How astir steak and a amusement for meal and best-in-class maturation for dessert? Investors tin bask conscionable that with The ONE Group Hospitality, Inc. (Nasdaq: STKS). The relation of 167 full-service experience-driven eating establishments precocious acquired Safflower Holdings, genitor of world-famous Benihana (known for hibachi-side cook performances) and RA Sushi. For the moment, STKS shares are connected sale, trading astatine a debt-adjusted EV of conscionable 5.2 times guardant EBITDA, little than fractional the aggregate commanded by Brinker International, Inc. and The Cheesecake Factory Inc. READ THE FULL REPORT HERE.